Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Opinion in Chemical Biology|April 21, 2019
Targeted protein degradation: elements of PROTAC designStacey-Lynn Paiva, Craig M CrewsJournal of Medicinal Chemistry|January 31, 2013
Exploring a new frontier in cancer treatment: targeting the ubiquitin and ubiquitin-like activating enzymesSara R da Silva, Stacey-Lynn Paiva, Julie L Lukkarila, et al.Journal of Medicinal Chemistry|January 12, 2017
Regulating the Master Regulator: Controlling Ubiquitination by Thinking Outside the Active SiteStacey-Lynn Paiva, Sara R da Silva, Elvin D de Araujo, et al.ACS Central Science|July 3, 2019
Targeted Protein Internalization and Degradation by ENDosome TArgeting Chimeras (ENDTACs)Dhanusha A Nalawansha, Stacey-Lynn Paiva, Diane N Rafizadeh, et al.ACS Central Science|March 4, 2020
Retraction of "Targeted Protein Internalization and Degradation by ENDosome TArgeting Chimeras (ENDTACs)"Dhanusha A Nalawansha, Stacey-Lynn Paiva, Diane N Rafizadeh, et al.Current Pharmaceutical Design|November 16, 2012
Targeting the ubiquitin E1 as a novel anti-cancer strategyWei Xu, Julie L Lukkarila, Sara R da Silva, et al.Bioorganic & Medicinal Chemistry Letters|August 14, 2016
A selective inhibitor of the UFM1-activating enzyme, UBA5Sara R da Silva, Stacey-Lynn Paiva, Matthew Bancerz, et al.Plos One|April 3, 2014
Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cellsG Wei Xu, Julia I Toth, Sara R da Silva, et al.Pageof 1